Alnylam Pharmaceuticals | Текущие Активы



Current Assets Изменить Дата
Acadia Pharmaceuticals USD 938.32M 150.03M 2024-12
Agios Pharmaceuticals USD 968.62M 3.02M 2025-03
Alnylam Pharmaceuticals USD 3.27B 27.03M 2025-03
Amgen USD 26.93B 2.1B 2025-03
Arrowhead Research USD 570.54M 124.93M 2024-12
BioMarin Pharmaceutical USD 3.47B 235.48M 2025-03
Incyte USD 3.23B 7.24M 2025-03
Ionis Pharmaceuticals USD 2.42B 201.36M 2025-03
Moderna USD 6.77B 1.33B 2025-03
Neurocrine Biosciences USD 1.72B 151.9M 2024-12
Novartis USD 29.7B 1.56B 2024-12
PTC Therapeutics USD 2.32B 950.88M 2025-03
Regeneron Pharmaceuticals USD 17.57B 9.64B 2025-03
Sanofi 42.59B 12.51B 2024-12
Sarepta Therapeutics USD 2.43B 640.93M 2025-03
Takeda JPY 2.75T 299.73B 2024-12
Tectonic Therapeutic USD 146.86M 15.74M 2024-12
Ultragenyx Pharmaceutical USD 817.12M 17.52M 2024-12
Vertex Pharmaceuticals USD 9.6B 207.7M 2024-12
Xencor USD 577.6M 4.27M 2024-12



Alnylam Pharmaceuticals Текущие Активы - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - May 2025.